BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35994024)

  • 1. Illuminating the Structural Basis of Tau Aggregation by Intramolecular Distance Tracking: A Perspective on Methods.
    Zeng Z; Fichou Y; Vigers M; Tsay K; Han S
    J Phys Chem B; 2022 Sep; 126(34):6384-6395. PubMed ID: 35994024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
    Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
    J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations.
    Meyer V; Holden MR; Weismiller HA; Eaton GR; Eaton SS; Margittai M
    J Biol Chem; 2016 Jun; 291(23):12271-81. PubMed ID: 27080260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Prion-Like Propagation: State of the Art and Current Challenges.
    Dujardin S; Hyman BT
    Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.
    Ramachandran G; Udgaonkar JB
    Biochemistry; 2013 Jun; 52(24):4107-26. PubMed ID: 23721410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.
    Kaniyappan S; Tepper K; Biernat J; Chandupatla RR; Hübschmann S; Irsen S; Bicher S; Klatt C; Mandelkow EM; Mandelkow E
    Mol Neurodegener; 2020 Jul; 15(1):39. PubMed ID: 32677995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spin Labeling and Characterization of Tau Fibrils Using Electron Paramagnetic Resonance (EPR).
    Meyer V; Margittai M
    Methods Mol Biol; 2016; 1345():185-99. PubMed ID: 26453213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
    Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
    Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
    Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
    Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travels with tau prions.
    Diamond MI
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):83-88. PubMed ID: 37950616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Assembly into Filaments.
    Pérez M; Cuadros R; Medina M
    Methods Mol Biol; 2018; 1779():447-461. PubMed ID: 29886549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading.
    Kundel F; Hong L; Falcon B; McEwan WA; Michaels TCT; Meisl G; Esteras N; Abramov AY; Knowles TJP; Goedert M; Klenerman D
    ACS Chem Neurosci; 2018 Jun; 9(6):1276-1282. PubMed ID: 29590529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.